AC

Amaury Claude Matthieu Marie Joseph Roquette

Director Nominee Director DIN 10052434
DIN 10052434 First appointment Feb 2023 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Feb 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Amaury Claude Matthieu Marie Joseph Roquette

Data last updated:

Amaury Claude Matthieu Marie Joseph Roquette was a Nominee Director at Drt-Anthea Aroma Chemicals Private Limited (2023–2024). The company operates in Chemicals and Materials.

DIN 10052434
Primary Designation Nominee Director
Industry Chemicals and Materials
First Appointment 28 Feb 2023

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director28 Feb 20232008₹538 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Drt-Anthea Aroma Chemicals Private Limited
Premium access

Shareholding and investment profile for Amaury Claude Matthieu Marie Joseph Roquette

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amaury Claude Matthieu Marie Joseph Roquette

Amaury Claude Matthieu Marie Joseph Roquette was first appointed on 28 Feb 2023 as Nominee Director at Drt-Anthea Aroma Chemicals Private Limited.

Amaury Claude Matthieu Marie Joseph Roquette held 1 earlier board appointment: Drt-Anthea Aroma Chemicals Private Limited (Nominee Director, 28 Feb 2023 to 18 Dec 2024).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available